{"id":"https://openalex.org/W7204837104","doi":"https://doi.org/10.1016/j.therap.2026.07.007","title":"Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data","display_name":"Distinct pattern of reported adverse event with SGLT2 inhibitors in heart failure: A pharmacovigilance study using VigiBase data","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204837104","doi":"https://doi.org/10.1016/j.therap.2026.07.007","pmid":"https://pubmed.ncbi.nlm.nih.gov/42760177"},"language":"en","primary_location":{"id":"doi:10.1016/j.therap.2026.07.007","doi":"https://doi.org/10.1016/j.therap.2026.07.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.therap.2026.07.007","pdf_url":null,"source":{"id":"https://openalex.org/S102552068","display_name":"Therapies","issn_l":"0040-5957","issn":["0040-5957","1958-5578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.therap.2026.07.007","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148796650","display_name":"Omar Chebbo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Omar Chebbo","raw_affiliation_strings":["Clinical Pharmacy Department, University Hospital of Montpellier, 34000 Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, University Hospital of Montpellier, 34000 Montpellier, France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035015657","display_name":"Fran\u00e7ois Roubille","orcid":"https://orcid.org/0000-0002-5288-9687","observed_orcids":["https://orcid.org/0000-0002-5288-9687"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210086516","display_name":"Physiologie et M\u00e9decine Exp\u00e9rimentale du Coeur et des Muscles","ror":"https://ror.org/003sscq03","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210086516","https://openalex.org/I4210096427"]},{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Roubille","raw_affiliation_strings":["Department of Cardiology, University Hospital of Montpellier, 34000 Montpellier, France; PhyMedExp, University of Montpellier, CNRS, INSERM, 34000 Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, University Hospital of Montpellier, 34000 Montpellier, France; PhyMedExp, University of Montpellier, CNRS, INSERM, 34000 Montpellier, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210086516","https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056419976","display_name":"Jean\u2010Luc Faillie","orcid":"https://orcid.org/0000-0003-0100-4073","observed_orcids":["https://orcid.org/0000-0003-0100-4073"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Luc Faillie","raw_affiliation_strings":["Pharmacovigilance Regional Centre, Department of Medical Pharmacology and Toxicology, CHU Montpellier, 34000 Montpellier, France; Desbrest Institute of Epidemiology and Public Health, Inserm, Univ Montpellier, 34000 Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacovigilance Regional Centre, Department of Medical Pharmacology and Toxicology, CHU Montpellier, 34000 Montpellier, France; Desbrest Institute of Epidemiology and Public Health, Inserm, Univ Montpellier, 34000 Montpellier, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047770371","display_name":"Nicolas Chapet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Chapet","raw_affiliation_strings":["Clinical Pharmacy Department, University Hospital of Montpellier, 34000 Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, University Hospital of Montpellier, 34000 Montpellier, France","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029038931","display_name":"Pascale Palassin","orcid":"https://orcid.org/0000-0003-2717-9437","observed_orcids":["https://orcid.org/0000-0003-2717-9437"]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Pascale Palassin","raw_affiliation_strings":["Pharmacovigilance Regional Centre, Department of Medical Pharmacology and Toxicology, CHU Montpellier, 34000 Montpellier, France. Electronic address: p-palassin@chu-montpellier.fr"],"raw_orcid":"https://orcid.org/0000-0003-2717-9437","affiliations":[{"raw_affiliation_string":"Pharmacovigilance Regional Centre, Department of Medical Pharmacology and Toxicology, CHU Montpellier, 34000 Montpellier, France. Electronic address: p-palassin@chu-montpellier.fr","institution_ids":["https://openalex.org/I4210093292"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5029038931"],"corresponding_institution_ids":["https://openalex.org/I4210093292"],"apc_list":{"value":3450,"currency":"USD","value_usd":3450},"apc_paid":{"value":3450,"currency":"USD","value_usd":3450},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.62645583,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.040300000458955765,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9950000047683716},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.953000009059906},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":1.0},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9879999756813049},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.996999979019165},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.75},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5450000166893005},{"id":"https://openalex.org/keywords/ketoacidosis","display_name":"ketoacidosis","score":0.8399999737739563},{"id":"https://openalex.org/keywords/fournier-s-gangrene","display_name":"Fournier's gangrene","score":0.9660000205039978},{"id":"https://openalex.org/keywords/amputation","display_name":"amputation","score":0.722000002861023},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.9100000262260437},{"id":"https://openalex.org/keywords/genitourinary-tract-infection","display_name":"genitourinary infections","score":0.9120000004768372},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.656000018119812},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.75},{"id":"https://openalex.org/keywords/reporting-odds-ratio","display_name":"reporting odds ratio","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.758899986743927},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7576000094413757},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5758000016212463},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5303999781608582},{"id":"https://openalex.org/C2779662365","wikidata":"https://www.wikidata.org/wiki/Q5416694","display_name":"Event (particle physics)","level":2,"score":0.446399986743927},{"id":"https://openalex.org/C3020169349","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug event","level":3,"score":0.3880000114440918},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3646000027656555},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.3483000099658966},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.3449999988079071},{"id":"https://openalex.org/C2987896495","wikidata":"https://www.wikidata.org/wiki/Q5416716","display_name":"Event data","level":3,"score":0.30660000443458557},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.2870999872684479},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.27160000801086426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2711000144481659},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.26260000467300415},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2619999945163727},{"id":"https://openalex.org/C3018822202","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Patient data","level":2,"score":0.26010000705718994},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.25279998779296875},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.25209999084472656}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.therap.2026.07.007","doi":"https://doi.org/10.1016/j.therap.2026.07.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.therap.2026.07.007","pdf_url":null,"source":{"id":"https://openalex.org/S102552068","display_name":"Therapies","issn_l":"0040-5957","issn":["0040-5957","1958-5578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapies","raw_type":"journal-article"},{"id":"pmid:42760177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42760177","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapie","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05755542v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-05755542","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapies, 2026, &#x27E8;10.1016/j.therap.2026.07.007&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.therap.2026.07.007","doi":"https://doi.org/10.1016/j.therap.2026.07.007","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.therap.2026.07.007","pdf_url":null,"source":{"id":"https://openalex.org/S102552068","display_name":"Therapies","issn_l":"0040-5957","issn":["0040-5957","1958-5578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapies","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1526927233","https://openalex.org/W2064716383","https://openalex.org/W2114823464","https://openalex.org/W2146264128","https://openalex.org/W2167186282","https://openalex.org/W2465883722","https://openalex.org/W2551481457","https://openalex.org/W2595061630","https://openalex.org/W2736492270","https://openalex.org/W2738105394","https://openalex.org/W2900413769","https://openalex.org/W2900732862","https://openalex.org/W2974260792","https://openalex.org/W3016435879","https://openalex.org/W3081830235","https://openalex.org/W3094458820","https://openalex.org/W3115984546","https://openalex.org/W3163839889","https://openalex.org/W3193297191","https://openalex.org/W4293354639","https://openalex.org/W4383665050","https://openalex.org/W4386151215","https://openalex.org/W4396577261","https://openalex.org/W4396696102","https://openalex.org/W4403389696"],"related_works":["https://openalex.org/W4403389696","https://openalex.org/W4388226035","https://openalex.org/W4280498195","https://openalex.org/W4283711577","https://openalex.org/W6958625488","https://openalex.org/W4390056756","https://openalex.org/W4285231864","https://openalex.org/W4410358435","https://openalex.org/W4405402710","https://openalex.org/W4403701648"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"AIMS:":[2],"Sodium-glucose":[3],"cotransporter":[4],"2":[5,11],"inhibitors":[6],"(SGLT-2i),":[7],"developed":[8],"for":[9,63,132,191,265],"type":[10],"diabetes":[12],"mellitus":[13],"(T2DM),":[14],"have":[15],"been":[16],"approved":[17,62],"in":[18,136,141,164,172,177,207,213,225,237],"symptomatic":[19],"heart":[20,243],"failure":[21,168],"(HF).":[22],"Comparison":[23],"of":[24,83,134,203,247,258],"their":[25],"safety":[26,54,231,267],"profiles":[27,232],"between":[28,46,113,195],"T2DM":[29,47,64,114,137,165],"and":[30,48,65,95,102,115,139,155,166,216,254],"HF":[31,49,116,127,142,173,208],"remain":[32],"scarce.":[33],"Using":[34],"international":[35],"pharmacovigilance":[36,74],"data,":[37],"reported":[38,111,163,171,224],"adverse":[39],"events":[40],"(AEs)":[41],"with":[42],"SGLT-2i":[43],"were":[44,67,85,107,160,181,221],"compared":[45],"indications.":[50,198],"METHODS:":[51],"Individual":[52],"case":[53],"reports":[55],"(ICSRs)":[56],"involving":[57],"dapagliflozin":[58],"or":[59],"empagliflozin,":[60],"both":[61],"HF,":[66],"collected":[68],"from":[69],"the":[70,120,196,245,263],"World":[71],"Health":[72],"Organization's":[73],"database":[75],"up":[76],"to":[77,109,201,219],"September":[78],"30,":[79],"2024.":[80],"Five":[81],"AEs":[82,112,130,204,217],"interest":[84],"specifically":[86],"investigated":[87],"including":[88],"ketoacidosis,":[89,253],"genitourinary":[90,192],"infection,":[91],"Fournier's":[92,150],"gangrene,":[93],"amputation":[94,156],"kidney":[96,167],"failure.":[97],"Reporting":[98],"odds":[99],"ratio":[100],"(ROR)":[101],"95%":[103],"confidence":[104],"interval":[105],"(CI)":[106],"calculated":[108],"compare":[110],"indication.":[117],"RESULTS:":[118],"Of":[119],"47,804":[121],"ICSRs":[122],"selected,":[123],"only":[124],"10.0%":[125],"involved":[126],"patients.":[128,143],"Serious":[129],"accounted":[131],"41.0%":[133],"cases":[135],"patients":[138],"44.2%":[140],"As":[144],"expected,":[145],"ketoacidosis":[146],"(14.6%":[147],"vs":[148,153,158,175,211],"4.1%),":[149],"gangrene":[151],"(2.3%":[152],"1.8%),":[154],"(0.5%":[157],"0.3%)":[159],"significantly":[161],"more":[162,170,222],"was":[169,189,205],"(6.1%":[174],"3.8%":[176],"T2DM).":[178],"The":[179],"differences":[180],"illustrated":[182],"by":[183,239],"significant":[184],"ROR.":[185],"However,":[186],"no":[187],"difference":[188],"evidenced":[190],"tract":[193],"infections":[194],"two":[197],"Median":[199],"time":[200],"onset":[202],"shorter":[206],"(111.5":[209],"days\u00b1198.7":[210],"264.9\u00b1664.9":[212],"T2DM,":[214],"p<0.001)":[215],"leading":[218],"death":[220],"frequently":[223],"this":[226],"subgroup.":[227],"CONCLUSION:":[228],"SGLT2":[229],"inhibitor":[230],"differ":[233],"across":[234],"indications,":[235],"shaped":[236],"part":[238],"patient":[240],"characteristics.":[241],"In":[242],"failure,":[244],"reporting":[246],"unexpected":[248],"serious":[249],"events,":[250],"such":[251],"as":[252],"a":[255],"higher":[256],"proportion":[257],"fatal":[259],"outcomes":[260],"sharply":[261],"reinforces":[262],"need":[264],"intensified":[266],"surveillance.":[268]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-09-01T00:00:00"}